SUMMARY An antigen capture immunoassay was developed for the detection of mycobacterial antigens in sera from patients with tuberculosis. The assay was evaluated together with an antibody measuring enzyme immunoassay in a clinical trial for serodiagnosis of tuberculosis.
Tuberculosis remains a major disease with many socioeconomic implications. The clinical spectrum in developed countries has changed: more than 30% of patients with pulmonary tuberculosis may present atypical chest x-rays,' and extrapulmonary disease represents an increasing proportion of all cases,2 which makes diagnosis more difficult.
Standard bacteriological techniques are generally unsatisfactory. Microscopic examination of sputum specimens may give a less than 50% positive yield, 3'4 and culture techniques, though more sensitive and providing definitive diagnosis,4 are expensive and require prolonged incubations.5
The development ofenzyme linked immunosorbent assays (ELISA) has stimulated renewed interest in serological tests for the diagnosis of tuberculosis.612
Although the reported results are encouraging, specific antibodies at levels of diagnostic importance are not detected in a relatively high proportion of patients with tuberculosis despite general hypergammaglobulinaemia. 13 -15 The reported inverse relation between antibody and immune complexes16 and the association of low antibody titres with heavily infected patients12 suggests that mycobacterial antigens are released into the blood circulation. Mycobacterial plasma membrane antigens were detected in the cerebrospinal fluid of patients with Accepted for publication 19 February 1986 tuberculous meningitis with a latex particle agglutination test. 17 In the inactive tuberculosis group the three sera with highest antibody activity were from patients who Fig. 2 shows the antibody activity. Specificity for active tuberculosis in the group with lung abnormalities was 97% with one false positive result from a patient with pneumonia. In the other control group (non-lung disease) specificity was 84%. Of the four false positive sera, the highest antibody activity was obtained from a 48 year old Asian patient treated for hypothyroidism. Two further samples taken three and six months later were also strongly positive, but the radiological and bacteriological results were negative. The three other patients were treated for diabetes mellitus, hypertension, and Crohn's disease.
Twenty nine sera from the groups with tuberculosis, including the false negative samples and 40 (Table  3) . This low test sensitivity for active disease was considered to be of limited diagnostic value. When the results of the ACIA were combined with those of the TB-ELISA, however (Fig. 3) , 28 samples (96'5%) were positive in either or both assays. Only one serum was negative in both tests and that was from a patient with genitourinary tuberculosis.
The mean antibody activity of the sera from the tuberculosis patients in the group positive for ACIA was 52 (SD 21) and that of the group negative for ACIA 98 (26). This strongly suggests that antigen detected in the serum may be inversely related to antibody activity. The only exception was a sample from a patient with disseminated disease with foci in both the lung and bone that was strongly positive in both assays. 
Discussion
Enzyme immunoassay techniques have been developed for tuberculosis, which are almost exclusively used to measure antibody titres. Promising results have been reported in these studies using crude mycobacterial extracts such as filtrates6 and cell sonicates, 19 -21 purified protein derivative,9 -"1 22 -24 or highly purified antigens including glycolipids25 and cytoplasmic proteins,7 8 11 which clearly show the spectrum of humoral responses in tuberculosis. The average sensitivity of most of these assays was about 85%, but because of limited clinical information it is difficult to establish why a substantial proportion of patients failed to produce antibodies at a significantly high titre.
In a recent study Krambovitis12 reported that low antibody activity in patients with pulmonary tuberculosis was associated with heavy infections and with microscopy positive culture positive sputa. It was suggested that release of mycobacterial antigens may lead to formation of immune complexes with the more reactive antibodies, resulting in a considerable reduction of specific antibody activity. Carr et al"6 found that 68% of patients with tuberculosis had high titres of circulating immune complexes, as measured by Clq binding. In many of these patients there was an inverse relation between immune complexes and specific antibody titres. Brostoff et a126 did not find such a correlation, but some patients with high values of immune complexes had no detectable antibody, indicating that immune complex formation may be responsible for some of the antibody negative cases. Measurement of Clq binding has limited diagnostic application in tuberculosis because of autoantibody complex formation,27 28 as well as immune complexes due to antigen antibody interaction. Samuel et al29 recently measured specific antibody and mycobacterial antigens that had been isolated from polyethylene glycol precipitated circulating immune complexes. Using radioimmunoassay techniques, they reported higher antigen titres in sputum positive cases as compared with sputum negative cases, a gradual decrease in antigen concentrations, and an increase in specific antibody during treatment. In the present study free antibody and mycobacterial plasma membrane antigens released by direct inactivation of serum were investigated. Release of antigens was facilitated by the use of edetic acid simplifying the extraction procedure. Enzyme assays were also preferred because of the drawbacks of radioimmunoassays.
The sensitivity of the antibody assay for active pulmonary tuberculosis, including relapsed infections, was 75%, and the specificity with other lung diseases 97%. Using the same cut off the sensitivity for extrapulmonary tuberculosis was 90% and the specificity 84%. These results are comparable with those of other reports.79 12 Patients with low antibody activity seemed to fall into two categories: one consisted of strongly direct microscopy positive culture positive cases, as reported earlier"2; and the other immunocompromised patients. Location and extent of the infection, degree of dissemination, and the immunological state of the host must therefore be important factors in determining the antibody response.
The sensitivity of the antigen assay for active tuberculosis was 45% with no false positive reactions. The results suggested a possible inverse relation between antibody activity and antigen detected but not with concentration of antigen. The level of dissemination, or the amount of antigen released, and the rate of formation and removal of immune complexes from circulation may have influenced this aspect. Antigen and antibody have been detected in the cerebrospinal fluid of patients with tuberculous meningitis.30 -32 Our own laboratory has also described a method of detection of mycobacterial antigens'7 and measurement of antibodies directed to specific mycobacterial antigens. '2 In the present study we detected antigen and antibody in the serum of patients with active pulmonary and extrapulmonary tuberculosis. The combined results of the two assays gave rise to improved sensitivity for active disease.
Comparison of the diagnostic performance of the two assay test with that of existing criteria shows that the efficiency (proportion of tests giving the correct result) of the test was superior to microscopic examination and comparable with culture results (Table 4) . A limitation of the test was the false positive rate given by the antibody assay inpatients. Interpretation of a positive antibody only result must therefore be considered together with supporting evidence from other accepted criteria, including prevalence of the disease in a particular area. Specific monoclonal antibodies to M tuberculosis antigens have been produced,33 and the use of such antibodies together with improved sensitivity of the ACIA may permit a change either in the dilution factor or in the baseline of positivity of the antibody assay, eliminating a high proportion of the false positive results.
The test described here is highly specific and sensitive but warrants further investigation to validate its clinical application. There is a long history of attempts to produce serological tests including that previously described by Nicholls and coworkers, 34 35 which subsequently proved not to be clinically useful. [36] [37] [38] We believe, however, that our present method is specific enough to be useful and may add considerably to the diagnosis of tuberculosis.
